中文摘要
肾细胞癌(RCC)约占所有肾脏恶性肿瘤的85%,其中肾透明细胞癌(KIRC)是最典型的亚型。三重基序(TRIM)家族参与癌症的发生、进展和治疗耐药。尽管TRIM36在多种癌症中表现出抗肿瘤作用,但其与KIRC的关系仍不清楚。在我们的研究中,我们研究了TRIM36与KIRC之间的关系。通过生物信息学分析和验证实验的结合,我们注意到KIRC中TRIM36表达升高,且TRIM36表达上调与KIRC较差的预后相关。
此外,我们的划痕愈合实验和Transwell迁移实验结果表明,TRIM36促进KIRC细胞的增殖和迁移。为了解潜在机制,我们筛选了相关基因并进行了富集分析。
我们发现TRIM36可能与5个枢纽基因相互作用,并参与KIRC的细胞周期和细胞分裂过程。此外,通过免疫浸润分析,我们发现TRIM36可能与6种TIL(肿瘤浸润淋巴细胞)(TILs)和6种免疫抑制剂相互作用。
总之,我们的研究确定TRIM36是一个有前景的生物标志物,并全面探索了其对KIRC增殖的促进作用。
展开英文摘要原文
Renal cell carcinoma (RCC) represents approximately 85 % of all renal malignant tumors, with kidney renal clear cell carcinoma (KIRC) being the most typical subtype. The tripartite motif (TRIM) family is involved in cancer initiation, progression, and therapy resistance. While TRIM36 has exhibited anti-tumor effects in various cancers, its relationship with KIRC remains unclear. In our research, we studied the relationship between TRIM36 and KIRC.
Through a combination of bioinformatic analyses and validation experiments, we noted a rise in TRIM36 expression in KIRC, and the upregulation of TRIM36 expression is associated with a poorer prognosis in KIRC. Also, our findings from wound healing assays and transwell migration assays showed that TRIM36 promotes the proliferation and migration of KIRC cells. To understand the underlying mechanisms, we screened relevant genes and conducted enrichment analysis.
We identified that TRIM36 may interact with 5 hub genes and involve in the cell cycle and cell division processes in KIRC.
Additionally, through immune infiltration analysis, we found that TRIM36 may interact with 6 tumor-infiltrating lymphocytes (TILs) and 6 immune inhibitors. In summary, our research identifies TRIM36 as a promising biomarker and comprehensively explores its promoting effect on the proliferation of KIRC.
论文信息
- 作者
- Zhang J、Zou B、Geng Y、Yin H、Qin B、Gao W、Lin X、Sun N
- 单位
- Xuzhou Medical University, Xuzhou, China.China
- 期刊
- Heliyon2025 Feb 28